These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37206067)

  • 1. Skeletal muscle mass and quality before preoperative chemotherapy influence postoperative long-term outcomes in esophageal squamous cell carcinoma patients.
    Ichinohe D; Muroya T; Akasaka H; Hakamada K
    World J Gastrointest Surg; 2023 Apr; 15(4):621-633. PubMed ID: 37206067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer.
    Ito N; Tajika M; Tanaka T; Yamada K; Takagi A; Onishi S; Abe T; Higaki E; Fujieda H; Inaba Y; Muro K; Kawashima H; Niwa Y
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.
    Ishida T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2021 Nov; 28(12):7185-7195. PubMed ID: 33876359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative skeletal muscle fat infiltration is a strong predictor of poorer survival in gallbladder cancer underwent surgery.
    Ashida R; Yamamoto Y; Aramaki T; Sugiura T; Okamura Y; Ito T; Ohgi K; Uesaka K
    Clin Nutr ESPEN; 2022 Dec; 52():60-67. PubMed ID: 36513487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
    Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
    Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Preoperative Skeletal Muscle Mass and Quality on the Survival of Elderly Patients After Curative Resection of Colorectal Cancer.
    Ojima Y; Harano M; Sumitani D; Okajima M
    J Anus Rectum Colon; 2019; 3(4):143-151. PubMed ID: 31768464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.
    Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Masui T; Mizumoto M; Hammad A; Mori A; Takaori K; Uemoto S
    Surgery; 2015 Jun; 157(6):1088-98. PubMed ID: 25799468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.
    Ozawa Y; Nakano T; Taniyama Y; Sakurai T; Onodera Y; Kamiya K; Hikage M; Sato C; Takaya K; Konno T; Unno M; Kamei T
    Esophagus; 2019 Oct; 16(4):345-351. PubMed ID: 30980203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Onishi S; Tajika M; Tanaka T; Yamada K; Kamiya T; Abe T; Higaki E; Fujieda H; Nagao T; Inaba Y; Muro K; Shimizu M; Niwa Y
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35159960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Preoperative Low Prognostic Nutritional Index and High Intramuscular Adipose Tissue Content on Outcomes of Patients with Oral Squamous Cell Carcinoma.
    Yoshimura T; Suzuki H; Takayama H; Higashi S; Hirano Y; Tezuka M; Ishida T; Ishihata K; Nishi Y; Nakamura Y; Imamura Y; Nozoe E; Nakamura N
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
    Shichinohe T; Uemura S; Hirano S; Hosokawa M
    Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Fujimoto Y; Ogawa K; Mori A; Hammad A; Tamai Y; Inagaki N; Uemoto S
    Liver Transpl; 2014 Nov; 20(11):1413-9. PubMed ID: 25088484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH; Jiang YH; Ji YL; Li B; Mao WM
    Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
    Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
    Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Oguma J; Ozawa S; Koyanagi K; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Esophagus; 2019 Oct; 16(4):395-401. PubMed ID: 31190104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Shirai H; Kaido T; Hamaguchi Y; Kobayashi A; Okumura S; Yao S; Yagi S; Kamo N; Taura K; Okajima H; Uemoto S
    Liver Cancer; 2018 Mar; 7(1):76-89. PubMed ID: 29662835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.